🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a multi-center randomized phase III clinical trial, the Inhibitor P...
Status
Terminated
Location
University of Arkansas Medical Sciences Childrens Hospital
Start Date
2021-10-11
Trial ID
NCT04303559
Treatments Being Tested
Hemophilia A (HA) is a genetic bleeding disorder resulting from a deficienc...
Status
Recruiting
Location
Arkansas Children's Hospital
Start Date
2023-08-16
Trial ID
NCT05022459
Treatments Being Tested
This is a non-interventional, multicenter, observational, international stu...
Status
Recruiting
Location
Arthur M. Blank Hospital
Start Date
2020-03-17
Trial ID
NCT04023019
The investigators propose to study longitudinal joint and bone density chan...
Status
Recruiting
Location
Orthopedic Hemophilia Treatment Center
Start Date
2019-04-04
Trial ID
NCT04131036
Treatments Being Tested
Low dose factor VIII prophylaxis is practiced around the world. Role of sta...
Status
Not Yet Recruiting
Location
Dhaka Medical College Hospital
Start Date
2025-06-01
Trial ID
NCT06938659
Treatments Being Tested
Von Willebrand Disease (VWD) is the most common inherited bleeding disorder...
Status
Recruiting
Location
The Center for Comprehensive Care and Diagnosis of Inherited Blood Disorders (CIBD)
Start Date
2022-11-01
Trial ID
NCT05500807
Treatments Being Tested
This study will evaluate if Eloctate is superior to Emicizumab in reducing ...
Status
Withdrawn
Location
Hemophilia Center of Western Pennsylvania
Start Date
2020-08
Trial ID
NCT02196207
Treatments Being Tested
This is a phase II multicenter open-label, single-arm prospective study to ...
Status
Active Not Recruiting
Location
UCSD Hemophilia and Thrombosis Treatment Center
Start Date
2022-08-31
Trial ID
NCT05345197
Treatments Being Tested
Introduction: Prophylaxis with emicizumab has substantially improved hemorr...
Status
Not Yet Recruiting
Location
Universidad de Oviedo
Start Date
2026-02-27
Trial ID
NCT07420348
Treatments Being Tested
This is a single arm, phase 4, prospective, open-label, United States singl...
Status
Terminated
Location
Indiana Hemophila @Thrombosis Center
Start Date
2019-05-15
Trial ID
NCT03921294
Treatments Being Tested